Prostate Cancer - Results from #1540

225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings. January 19, 2024

Decreased Opioid Use and Equivalent Pain Score Outcomes After Robotic Urologic Surgery Using a Simplified Opioid Minimization Protocol: A Safety-Net Hospital Experience January 19, 2024

The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer. January 18, 2024

Quality of information and appropriateness of Open AI outputs for prostate cancer. January 18, 2024

Phase 1 Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer Progressing on Enzalutamide. January 18, 2024

De-Escalation of Therapy for Prostate Cancer. January 18, 2024

Radiation after radical prostatectomy in elderly patients - a SEER database-derived competing-risk survival analysis of propensity score-matched age groups. January 18, 2024

Outcomes of lateral approach in robot-assisted radical prostatectomy: insights from a single-surgeon experience. January 17, 2024

Imaging GRPr Expression in Metastatic Castration-Resistant Prostate Cancer with [68Ga]Ga-RM2-A Head-to-Head Pilot Comparison with [68Ga]Ga-PSMA-11. January 17, 2024

Diagnostic Performance of 68Ga-PSMA-11 PET/CT Versus Multiparametric MRI for Detection of Intraprostatic Radiorecurrent Prostate Cancer. January 17, 2024

Bispecific T-cell Engagers in Metastatic Castration-Resistant Prostate Cancer. January 17, 2024

Isolating the Drivers of Racial Inequities in Prostate Cancer Treatment. January 17, 2024

Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States. January 17, 2024

Do Patients with Prostate Cancer Benefit from Exercise Interventions? A Systematic Review and Meta-Analysis. January 17, 2024

Economic evaluation of exercise interventions for individuals with cancer: A systematic review. January 17, 2024

ArteraAI Receives Medicare Payment Rate for the ArteraAI Prostate Cancer Test January 16, 2024

Improving physical activity among prostate cancer survivors through a peer-based digital walking program. January 16, 2024

Diagnostic accuracy of bone scan at different PSA levels in biochemical recurrence of prostate cancer. January 16, 2024

Defining the role of multiparametric MRI in predicting prostate cancer extracapsular extension. January 16, 2024

A Phase II Prospective Blinded Trial of MRI and In-Bore Biopsy in Active Surveillance for Prostate Cancer. January 16, 2024

Page 78 of 1438